Center for Iron & Heme Disorders at the University of Utah
铁中心
基本信息
- 批准号:10458584
- 负责人:
- 金额:$ 67.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-05 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAnemiaAreaAssisted Living FacilitiesAwardBindingBiochemicalBiochemistryBiologicalBiological AssayBiological ProcessBiomedical ResearchCell RespirationCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinical ResearchClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCopperCultured CellsDNA biosynthesisDetectionDiamond-Blackfan anemiaDiseaseEducational workshopEnzymesEquipmentErythropoiesisFacultyFeesFree RadicalsFundingGene MutationGene-ModifiedGenerationsGenesGlobinGoalsHematologyHematopoiesisHemeHeme GroupHeme IronHemeproteinsHemoglobinHomeostasisHuman GeneticsIndividualInstitutionInterest GroupIronIron OverloadLettersLiquid substanceMedicineMentorsMetabolic DiseasesMetabolic PathwayMetabolismMetalsMethodsMolecularMononuclearMutationNational Institute of Diabetes and Digestive and Kidney DiseasesNon-MalignantPathologyPersonsPhenotypePilot ProjectsPlayPorphyriasPorphyrinsPostdoctoral FellowProgress ReportsProteinsProteomicsReagentRecording of previous eventsResearchResearch ActivityResearch DesignResearch PersonnelResearch Project GrantsResearch TrainingResourcesRoleScientistSeriesServicesSourceSulfurTechnologyTrainingTransition ElementsUniversitiesUtahVisitbasecofactorcost effectivedesigngenome editingheme biosynthesishuman diseaseinterestmacromoleculemedical schoolsmeetingsmembermetabolomicsmetal metabolismmetal metabolism disordermultidisciplinarynew technologynext generationnoveloperationoxygen transportpre-doctoralprogramsprotein metabolitestemstem cell biologysymposiumsynergismtranscription activator-like effector nucleases
项目摘要
Project Summary:
The proposed University of Utah Cooperative Centers of Excellence in Hematology (CCEH) brings together 38
investigators whose research activities are focused on various aspects of iron and heme metabolism and non-
malignant hematology. Iron plays an essential role in many biological processes including heme synthesis,
oxygen transport, cellular respiration and DNA synthesis. Malregulation of iron homeostasis, either from
deficiency or excess, results in disease. Heme is a key component of hemoglobin and other hemoproteins, but
heme also plays a regulatory role in a number of metabolic pathways. Disorders of heme biosynthesis are
responsible for an important group of human diseases, namely the porphyrias. The Utah Center for Iron and
Heme Disorders (CIHD) will support the activities of a Research Base of 38 investigators whose research
projects focus on the roles of iron, porphyrins and heme in eukaryotic metabolism. The activities of center
members encompass both basic and clinical studies designed to identify disease mechanisms. To accomplish
our goals, we propose an Administrative Core and four Biomedical Research Cores. The majority of the cores
are already present and have been adjusted to meet the needs of the CIHD. These include: an Iron and Heme
Core, which can assay and quantitate metals, porphyrins, heme biosynthetic enzymes and iron-binding and
other proteins; a Metabolomics Core, which provides metabolomic phenotyping and molecular identification; a
Mutation Generation and Detection Core, which provides cutting edge genome editing through CRISPR and
TALEN reagents; and a new core in this renewal, the Protein-Metabolite Interactomics Core that provides
proteomics services but adds the unique technology of identification of metabolites that interact with a protein
and may post-translationally modify the protein in novel ways. The services provided by these cores will enable
individual investigators to: 1) identify the role of genes in hematopoiesis or iron overload; 2) determine the
effects of gene modification or mutations on metabolism in cultured cells or biological fluids; and 3) identify at
the biochemical level the effect of mutations or conditions that affect iron and heme homeostasis on all levels.
The Administrative Core will provide budgetary and scientific guidance to CIHD activities. Core recharge fees
will be used to enhance and expand core operations. An Enrichment Program is designed for trainees and
young investigators in the fields of nonmalignant hematology and for senior investigators who wish to enter this
field. The Research Base is drawn from both the University of Utah and other institutions, with half of the
members belonging to institutions outside of Utah. We have increased the Research base from 22 to 38 with
the addition of ~4 investigators each year. The goals of the CIHD are to be a national resource for studies
involving iron and heme and to inspire the next generation of investigators focused on iron, heme and
nonmalignant hematology.
项目总结:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Eric COX其他文献
JAMES Eric COX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Eric COX', 18)}}的其他基金
Center for Iron & Heme Disorders at the University of Utah
铁中心
- 批准号:
10676099 - 财政年份:2016
- 资助金额:
$ 67.28万 - 项目类别:
Center for Iron & Heme Disorders at the University of Utah
铁中心
- 批准号:
10206671 - 财政年份:2016
- 资助金额:
$ 67.28万 - 项目类别:
Agilent 7200 GC/Q-TOF for the University of Utah
犹他大学的 Agilent 7200 GC/Q-TOF
- 批准号:
9074776 - 财政年份:2016
- 资助金额:
$ 67.28万 - 项目类别:
Q-ToF Mass Spectrometer for the University of Utah MS and Proteomics Core
用于犹他大学 MS 和蛋白质组学核心的 Q-ToF 质谱仪
- 批准号:
8826327 - 财政年份:2015
- 资助金额:
$ 67.28万 - 项目类别:
Agilent 6550 QTOF system for U of Utah
适用于犹他大学的 Agilent 6550 QTOF 系统
- 批准号:
8447176 - 财政年份:2013
- 资助金额:
$ 67.28万 - 项目类别:
相似国自然基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
- 批准号:82302715
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
- 批准号:31200592
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
- 批准号:
24K10442 - 财政年份:2024
- 资助金额:
$ 67.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
- 批准号:
23K15297 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
- 批准号:
23K14452 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
- 批准号:
23KJ0074 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
- 批准号:
10752968 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
- 批准号:
10735765 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
- 批准号:
10735366 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
- 批准号:
10575222 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
- 批准号:
10583807 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
- 批准号:
10564553 - 财政年份:2023
- 资助金额:
$ 67.28万 - 项目类别:














{{item.name}}会员




